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Summary
 
Transient expression of constitutively active Rac1 derivatives, (G12V) or (Q61L), was 
sufficient to induce phagocyte NAPDH oxidase activity in a COS-7 cell model in which human 
cDNAs for essential oxidase components, gp91phox, p22phox, p47phox and p67phox, were 
expressed as stable transgenes.  Expression of constitutively active Rac1 in “COSphox” cells 
induced translocation of p47phox and p67phox to the membrane.  Furthermore, translocation of 
p47phox was induced in the absence of p67phox expression, even though Rac does not directly 
bind p47phox.  Rac effector domain point substitutions (A27K, G30S, D38A, Y40C), which can 
selectively eliminate interaction with different effector proteins, impaired Rac1V12-induced
 superoxide production.  Activation of endogenous Rac1 by expression of constitutively active 
Rac-GEF derivatives was sufficient to induce high-level NADPH oxidase activity in COSphox 
cells.  The constitutively active form of the hematopoietic-specific GEF, Vav1, was the most 
effective at activating superoxide production, despite detection of higher levels of Rac1-GTP 
upon expression of constitutively active Vav2 or Tiam1 derivatives. These data suggest that Rac 
can play a dual role in NADPH oxidase activation, both by directly participating in the oxidase 
complex and by activating signaling events leading to oxidase assembly, and that Vav1 may be 
the physiologically relevant GEF responsible for activating this Rac-regulated complex.
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Introduction
The phagocyte NADPH oxidase plays an essential role in innate immunity by catalyzing 
the production of reactive superoxide in conjunction with phagocytosis to facilitate pathogen 
killing and digestion (1,2).  Genetic defects in essential NADPH oxidase components result in 
chronic granulomatous disease (CGD), a condition characterized by recurrent, often life-
threatening infections (3).  Binding of inflammatory mediators to specific phagocytic cell surface 
receptors triggers assembly of the multicomponent NADPH oxidase.  Tight regulation of 
NADPH oxidase activation is required because excessive or inappropriate superoxide release can 
damage adjacent host tissue, as has been implicated in pathologic inflammatory conditions (4,5).  
The active oxidase is comprised of two integral membrane subunits, gp91phox and 
p22phox, which form flavocytochrome b558, and three cytosolic components, p47phox, p67phox, and 
Rac, which must translocate to the membrane to activate electron flow through the 
flavocytochrome (1).  In whole cells, p47phox and p67phox associate via reciprocal SH-3 
domain interactions (6,7).  Membrane translocation of both p47phox and p67phox is dependent 
upon phosphorylation of p47phox (1-3), which undergoes a conformational change (8) to expose 
an SH-3 domain that binds to a proline-rich region in the p22phox flavocytochrome subunit (9-
14).  p47phox translocates to the membrane in the absence of p67phox expression but p67phox 
remains cytosolic in the absence of p47phox in phagocytes derived from p67phox -/- or 
p47phox -/- CGD patients, respectively (9,15).  Analysis of NADPH oxidase activation in cell-free 
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systems has shown that the addition of p47phox plus an anionic amphiphile, which is thought to 
substitute for phosphorylation events, is required for the high affinity binding of p67phox and 
Rac to flavocytochrome b558 (16,17), although this requirement can be overcome by the 
addition of high concentrations of Rac and p67phox (16,18-20).  Thus, p47phox functions as an 
essential adaptor protein linking and orienting p67phox with the flavocytochrome subunits (20). 
A second important event required for oxidase activation is Rac activation and membrane 
translocation (1,2).  The mechanisms by which Rac regulates the NADPH oxidase are 
incompletely understood.  In cell-free oxidase reconstitution assays, either the GTP-bound form 
of Rac1 or Rac2 is essential for high-level superoxide production (21,22).  Rac-GTP binds the 
N-terminal TPR (tetratrico repeat) region of p67phox and may also interact directly with the 
flavocytochrome in the assembled oxidase complex (23-29).  In human neutrophils, 
hematopoietic-specific Rac2 is the major isoform, and ubiquitously-expressed Rac1 is a minor 
isoform (25).  Recent in vivo evidence for Rac regulation of phagocyte oxidase function has 
come from analysis of Rac2-/- mice (30,31) and from a patient with recurrent bacterial 
infections who was found to express a dominant-negative form of Rac2 (32,33).  
Guanine nucleotide exchange factors (GEFs) activate Rac by catalyzing the exchange of 
bound GDP for GTP (34,35).  Rac-GTP can then interact with numerous downstream effector 
proteins, activating biochemical pathways that include those regulating actin remodeling, cell 
cycle progression, and gene expression, in addition to NADPH oxidase activity in phagocytes 
(36,37).  Rac has a low rate of intrinsic GTP hydrolysis, which is accelerated by GTPase 
activating proteins (GAPs), causing it to revert to an inactive GDP-bound conformation (36).  
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Two Rac point mutants, (Q61L) or (G12V), are deficient in GTPase activity and therefore 
constitutively active (36,38,39). 
Specific point substitutions in the Rac effector domain (amino acids 26 – 45), which 
changes conformation upon GTP binding, lead to selective defects in binding downstream 
effector proteins. Point mutations (A27K) or (G30S) abrogate Rac interaction with p67phox and 
NADPH oxidase activity in cell-free assays (40,41).  Effector domain point substitutions 
(D38A) or (Y40C) abrogate Rac/Cdc42 interaction with target effector proteins containing a 
conserved Rac/Cdc42-binding sequence known as a CRIB motif, including the p21 activated 
kinases (PAKs) (36,42,43).  p67phox interacts with Rac via a sequence interspersed in its N-
terminal TPR motifs rather than via a CRIB motif (40) and has normal affinity for a C40 Rac 
derivative (43).  Mutation or deletion of the Rac “insert domain” (amino acids 124 – 135), a 
surface-exposed α-helical region, impairs NADPH oxidase activity in arachidonic acid 
activated cell-free assays (29,44).  The Rac insert domain is not involved in binding to p67phox 
but rather is postulated to directly interact with the flavocytochrome (27,29).    
To develop genetic approaches for characterizing signaling pathways regulating 
phagocyte NADPH oxidase assembly and activation, we recently developed a readily 
transfectable cell model in which human cDNAs for all four essential oxidase components, 
gp91phox, p22phox, p47phox and p67phox, were expressed as stable transgenes in COS-7 cells (45).  
COS-7 cells express the Rac1 but not the Rac2 isoform.  The transgenic “COSphox” cells 
exhibit high level NADPH oxidase activity induced using either phorbol myristate acetate 
(PMA) or arachidonic acid, two soluble stimuli commonly used to activate the neutrophil 
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NADPH oxidase.  Agonist-elicited superoxide production by the COSphox cells was 
significantly inhibited by transient expression of dominant negative Rac mutants or by 
overexpression of the inhibitory Rac-binding protein, RhoGDI.  These results supported an 
important role for Rac in regulating the NADPH oxidase in COSphox cells, consistent with the 
genetic data in murine and human neutrophils.
In the current study we show that Rac activation in COSphox cells, either by expression 
of constitutively active Rac exchange factors or by expression of constitutively active Rac 
derivatives, is sufficient to induce membrane translocation of p47phox and p67phox and activate 
the NAPDH oxidase, in the absence of any other stimulus.  Constitutively active Vav1 was more 
effective at activating superoxide production than Vav2 or Tiam1.  Selective Rac effector 
domain point substitutions, which disrupt interaction with different downstream effector 
proteins, inhibited Rac1V12-induced NADPH oxidase activity, supporting a role for multiple 
effectors in mediating Rac-GTP oxidase activation.  Our data suggest that Rac can regulate 
phagocyte NADPH oxidase activity both as a direct participant in the oxidase complex and also 
as an activator of signaling events leading to oxidase assembly. 
Experimental Procedures
Materials.  Chemicals were purchased from Sigma unless otherwise stated.  Phosphate 
buffered saline (PBS), penicillin/streptomycin, trypsin/EDTA, glycerol, Lipofectamine Plus and 
Dulbecco’s modified Eagle’s low glucose medium (DMEM) were purchased from Gibco BRL.  
Mouse monoclonal antibodies against Rac1 (clone 23A8) and Myc-epitope tag 9E10 were 
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purchased from Upstate, Inc. (Lake Placid, NY).  Polyclonal rabbit serum raised against p47phox 
and p67phox was generously provided by David Lambeth (Emory University).  Paul Heyworth 
(Scripps Research Institute) kindly provided mouse monoclonal antibody against p47phox.
Expression Vectors.  Full-length cDNAs for human Rac1, Rac2, and Cdc42 were 
subcloned downstream of a Myc-epitope tag in pRK5 (Pharmingen).  PCR mutagenesis was 
used to introduce (G12V) or (Q61L) point mutations in Rac or Cdc42 cDNA templates.  A 
polyglutamate-tag was subcloned downstream of the Myc-epitope tag and upstream of the 
mutant Rac (G12V) cDNAs.  Rac1 (∆124-135/A136) cDNA was generated by PCR as described 
(44).  Rac1 (V12/∆124-135/A136) was generated by restriction digest and ligation of a Bsu36 
I/Pst I fragment, encompassing the C-terminal region of Rac1 (∆124-135/A136), into pRK5 
expression vector containing the N-terminal region of Rac1 (G12V).  Rac1 double mutants, 
(V12/ K27), (V12/S30), (V12/A38), (V12/C40), (V12/N130), (V12/E132), and (V12/R134), 
were generated using the QuikChange mutagenesis kit (Stratagene) to introduce each of the 
second mutations into a Rac1V12 template.  All mutant Rac cDNAs were sequenced in entirety.  
Human p47phox cDNA was subcloned into pRK5 and human p67phox cDNA was subcloned 
upstream of a Myc-epitope tag in pcDNA3 (Invitrogen).  Amino-truncated cDNAs for mouse 
Vav1∆N-186 and human Vav2∆N-191, each subcloned in pAX142 (46,47), were graciously 
provided by Channing Der (University of North Carolina).  Amino-truncated cDNA for human 
Tiam1∆N-401 (encoding a 135kD derivative) subcloned in pCANmyc (48) was generously 
provided by Gideon Bollag (Onyx Pharmaceuticals).
   Cell Culture and Transfection.  COS-7 cell lines were previously established which 
stably expressed human cDNAs encoding gp91phox, p22phox, p47phox, and p67phox, or 
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combinations of these, as stable transgenes (45).  Transgenic COS-7 cell lines were grown in 
DMEM plus 10% heat inactivated fetal calf serum (Hyclone), 50 units/ml penicillin, 50µg/ml 
streptomycin, 0.2 mg/ml hygromycin (Calbiochem), 1.8 mg/ml neomycin and 1 µg/ml 
puromycin.  COS-7 cell lines were transiently transfected using Lipofectamine Plus per 
manufacturer’s instructions.  Transfection efficiency averaged 25 – 35%, as determined by 
immunohistochemistry to detect expression of a Myc-epitope tag.  Cells were harvested 21 
hours post-transfection by incubating with trypsin/EDTA for 5 minutes at 37C, as previously 
described (45).
   Measurement of NADPH Oxidase Activity.  Superoxide production by whole COS cells, 
harvested by brief trypsinization as described above, was measured in a quantitative kinetic assay 
based on the superoxide dismutase-inhibitable reduction of cytochrome c.  Assays were 
performed at 37C using a Thermomax microplate reader (Molecular Devices) as described 
previously (45,49) except no stimulus was added. Superoxide production was quantified using an 
extinction coefficient of 21.1 mM-1cm-1 for cytochrome c.  The maximum rate of superoxide 
generation over a five-minute interval was calculated using SOFTMAX version 2.0.  
Alternatively, qualitative assessment of NADPH oxidase activity in single cells was performed 
using the nitroblue tetrazolium (NBT) test; cells were incubated for 30 min at 37C in PBSG 
containing NBT. Cells were then fixed with methanol, stained with 0.2% safrinin, and counted at 
400x magnification.
   Indirect Immunofluorescence and Confocal Microscopy.  Cells were seeded on glass 
coverslips and transfected with constitutively active Rac derivatives the following day.  After 
overnight serum starvation, cells were fixed with 4% paraformaldehyde, permeabilized with 
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0.05% Triton X-100, and blocked with 2% bovine serum albumin (BSA) + 1% normal goat 
serum (NGS) in PBS.  Cells were stained with polyclonal p47phox or p67phox antisera plus 
monoclonal Myc Ab (to detect expression of transgenic Rac derivatives) diluted in 2% BSA/1% 
NGS/PBS for 30 minutes at 37C.  Cells were washed thoroughly with PBS, then incubated with 
FITC-conjugated goat-anti-rabbit and Cy3-conjugated goat-anti-mouse secondary antisera 
(Jackson ImmunoResearch Laboratories, West Grove, PA) diluted 1:100 in 2% BSA/1% 
NGS/PBS.  Alternatively, cells were stained with p47phox monoclonal antibody followed by 
FITC-conjugated goat-anti-mouse Ab.  Coverslips were mounted on glass slides with1% 
DABCO/ 50% glycerol.  Focal planes were imaged at 0.4µm intervals using the Zeiss 510 laser 
scanning confocal microscope (100X PlanApo 1.4 NA objective) equipped with LSM510 digital 
imaging software.  Three adjacent focal planes were averaged using Metamorph software.  Color 
images were converted to greyscale with Adobe Photoshop 6.0.  As a control, Rac1L61-
activated COSphox cells were incubated with fluorophore-conjugated secondary antibodies only 
and these cells exhibited negligible background staining (not shown).  As controls for combined 
primary and secondary antibody background staining, Rac1L61-activated COS cell lines that did 
not express p47phox were stained with p47phox antibody and processed in parallel with the test 
samples described above.  Likewise Rac1L61-activated COS cell lines that did not express 
p67phox were stained with p67phox antibody and processed as described.  The level of non-specific 
background staining in the control cells was well below the level of specific staining in the test 
cells (not shown).    
Analysis of Protein Expression and Membrane Translocation Assay.  Cells were 
harvested as described above.  Whole cell lysates were prepared and analyzed by 
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immunoblotting as previously described (45).  To examine membrane localization, cells were 
disrupted in a Dounce homogenizer and  fractionated by high-speed centrifugation over a 
discontinuous 20%/38% sucrose gradient, as previously described (45).  Densitometric analysis 
of films was performed using the Eagle Eye II Still Video System and associated software 
(Stratagene).  Protein dilutions and multiple exposures were analyzed to ensure that this analysis 
was performed in the linear range.
Rac Activation Assay.  PAK1 p21-binding domain (PBD-GST) was expressed in
 Escherichia coli strain BL21 and purified as described (50).  21 hours post-transfection, COS cells 
were detached with trypsin, washed, and resuspended in PBS at 5 x 106 cells/ 0.5 ml.  20µg 
PAK1 PBD-GST recombinant protein was added and cells were lysed by the addition of 2x 
Mg2+ lysis/wash buffer (MLB from Upstate) supplemented with 20µg/ml chymostatin, 2mM PMSF, 
10µM leupeptin, 5 mM Na3VO4 and 25 mM NaF.  The lysate was cleared, 30µl glutathione-
Sepharose 4B beads (Amersham Pharmacia) were added and the binding reaction was incubated 
1 hour at 4C.  Beads were pelleted and washed 3x with MLB then finally resuspended in 30µl 
Laemmli sample buffer.  Aliquots of supernatant and pulldown samples were electrophoresed 
and the proteins analyzed as described above.  Rac detected in the supernatant was assumed to be 
Rac-GDP and that in the pulldown Rac-GTP, with the sum representing total Rac.
   Statistical Analysis.  Results were analyzed using Instat software.  The effects of 
transfecting different cDNAs were compared using the Student t-test or ANOVA and Student-
Newman-Keuls multiple comparisons test, as indicated.  P-values ≤ 0.05 were considered 
significant.  Data are expressed as mean ± SE.
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Results
  Expression of constitutively active Rac1 induces superoxide production in COSphox 
cells.  We previously developed a heterologous cell model in which human cDNAs for all four 
essential oxidase components, gp91phox, p22phox, p47phox and p67phox, were expressed as 
stable transgenes in COS-7 cells (45).  COS-7 cells express the Rac1 but not the Rac2 isoform.  
The transgenic “COSphox” cells produced superoxide at a rate of 11 ± 0.87 nmol/107 cells/min 
(Vmax, n=43) in response to 0.4 µg/ml phorbol myristate acetate (PMA) and at a rate of 35 ± 3.5 
nmol/107 cells/min (n=11) in response to 100µM arachidonic acid.  This compared favorably to 
human neutrophils, which, when tested under the same conditions, exhibited PMA-elicited 
Vmax of 47 ± 3.4 nmol/107 cells/min and arachidonic acid-elicited Vmax of 41 ± 4.3, both n=5 
(45).  
In the current study, we found that high-level superoxide production could be induced in 
the COSphox cells by transient expression of constitutively active Rac1 (Q61L) or (G12V) 
derivatives, in the absence of any other stimulus (Fig 1A).  COSphox cells transfected with 
Rac1L61 produced superoxide at 13 ± 0.5 nmol/107 cells/min (n=4), whereas cells transfected 
with Rac1V12 produced superoxide at 5.8 ± 0.8 nmol/107 cells/min (n=10), consistent with the 
L61 derivative having higher affinity for both GTP and p67phox (38,39).  Using nitroblue 
tetrazolium (NBT) to detect superoxide production by individual cells, we determined that 29%
 ± 2.5 (n=3) of Rac1L61-transfected cells were NBT-positive. The percentage of NBT-positive 
cells was comparable to the transfection efficiency of 25 – 35%, determined by 
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immunohistochemistry to detect expression of a Myc-epitope tag.  Had the Rac1L61 been 
expressed in all of the cells instead of ~30% of the cells, the measured rate of Rac1L61-elicited 
superoxide production in the cytochrome c reduction assay would have been comparable to that 
elicited by arachidonic acid and significantly higher than that elicited by PMA.  Expression of 
wild type Rac in COSphox cells did not induce phagocyte NADPH oxidase activity over 
background observed with transfection of empty vector (Fig. 1A).  Superoxide production was 
not elicited by closely related (70% homologous) Cdc42 containing an activating (Q61L) 
mutation (Fig 1A).  Transgenic Rac expression exceeded that of endogenous Rac1 by about 20-
fold on a per mg total protein basis (Fig 1B). The overexpressed, epitope-tagged Rac migrated 
as two bands (Fig 1B) representing post-translationally isoprenylated and unprocessed forms of 
Rac (unpublished data).  Cdc42L61 was expressed at similar levels to the Rac derivatives (data 
not shown).   
p47phox expression is required for optimal Rac1L61-induced superoxide production in 
COSphox cells.  Although p47phox is essential for NADPH oxidase assembly in activated 
neutrophils or in standard cell-free assays, superoxide production under certain cell-free 
conditions can be obtained in the absence of p47phox when sufficiently high concentrations of 
purified recombinant Rac and p67phox are added either to vesicles prepared from detergent 
solubilized phagocyte membrane or to purified, relipidated flavocytochrome (16,18-20,29).  To 
determine whether activated-Rac induced superoxide production in the COSphox cells had a 
requirement for p47phox expression, we transiently transfected a COS cell line, which stably 
expressed gp91phox, p22phox, and p67phox, with vectors for expression of either Rac1L61, or 
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Rac1L61 and p47phox, or Rac1L61 and p67phox.  p67phox was stably expressed in the COS-
91,22,67 cells at a level comparable to that in human neutrophils on a per mg total protein basis.  
Transient transfection of p67phox further increased its level of expression by about 2.5-fold on a 
per mg total protein basis, or by ~7.5-fold in the cells in which it was expressed, based on the 
transient transfection efficiency of ~30%.  Expression of Rac1L61 induced some superoxide 
production when p67phox was overexpressed under these conditions, consistent with results 
obtained under some cell-free conditions using purified NADPH oxidase components.  
However, substantially higher levels of superoxide were produced when COS-91,22,67 cells 
were transfected with p47phox and Rac1L61 (Fig 2), demonstrating that p47phox was an 
important participant in activated-Rac induced NADPH oxidase activity in the COS cell model, 
as also observed in neutrophils and when using standard cell-free assay conditions.
   Specific mutations in the Rac effector and insert domains impair Rac1V12-induced 
NADPH oxidase activation.  To investigate the mechanisms by which Rac-GTP induces 
NADPH oxidase activation, we examined whether specific effector or insert domain mutations, 
which selectively eliminate interactions with different target effector proteins, would affect the 
ability of Rac1V12 to activate the phagocyte NADPH oxidase in COSphox cells.  Rac1V12 was 
chosen for these experiments rather than Rac1L61 because the L61 mutation has been shown to 
override inhibitory effector domain mutations in some instances (38). 
Effector domain point mutations at either amino acid 27 or 30, which abrogate binding to 
p67phox (40), had the greatest impact on Rac1V12-activated superoxide production (Fig 3A).  
In fact, cells expressing Rac1V12/K27 or Rac1V12/S30 generated no superoxide over low-level 
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background amounts observed with empty vector-transfected cells, supporting the importance of 
the interaction between Rac and p67phox for NADPH oxidase activity.  However, effector 
domain point substitution Y40C, which abrogates Rac interaction with CRIB-domain–dependent 
effector proteins without affecting affinity for p67phox, also reduced Rac1V12-induced 
NADPH oxidase activity by over 2-fold (Fig 3A).  A similar reduction was observed with the 
(D38A) derivative (Fig 3A), which has reduced affinity both for p67phox and likely for CRIB-
domain dependent effectors (24,42).  Insert domain deletion (∆124-135) or point substitutions 
K132E or L134R had a smaller inhibitory effect on Rac1V12-dependent activation of 
superoxide production (Fig 3A).  For these experiments, approximately 7-fold less of the 
expression vector was used, compared to the experiments shown in Fig 1, to reduce the relative 
level of recombinant Rac1 protein expression.  Transfection efficiency was ~20% under these 
conditions.  Equivalent expression of the Rac derivatives was confirmed by immunoblotting (Fig 
3B).  Levels of the transgenic Rac derivatives exceeded endogenous Rac1 expression by about 
3-fold on a per mg total protein basis, as determined by densitometric analysis of immunoblots 
(Fig 3B). Normalizing for transfection efficiency, the level of transgenic Rac exceeded 
endogenous by ~15-fold in cells which expressed the transgenic Rac derivatives.
The effect of further over-expressing selected Rac1 derivatives was examined by 
transfecting with a ~7-fold higher amount of each expression vector.  Under these conditions, 
the Rac1V12/S30 derivative, which does not bind p67phox, still did not induce superoxide 
production over background observed with empty vector (Fig 3C), despite substantially 
increased transgenic protein expression (Fig 3D).  The Rac1V12/C40 derivative, which binds 
p67phox but not CRIB-domain dependent effectors, was 2-fold less effective than Rac1V12 at 
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activating superoxide production, even when further overexpressed (Fig 3C, D), supporting the 
concept that effectors other than p67phox participate in Rac-GTP induced oxidase activation.  
At the higher protein expression level, the insert region deletion derivative elicited superoxide 
production that was comparable to Rac1V12 (Fig 3C). Thus, the moderately inhibitory effect of 
insert region deletion on activated-Rac induced superoxide production was overcome by higher 
expression of Rac1V12/∆insert in the COSphox cells.
Expression of activated Rac is sufficient to induce p47phox and p67phox membrane 
translocation.  NADPH oxidase activity in COSphox cells expressing constitutively active Rac 
derivatives was substantially dependent on p47phox expression (Fig 2), similar to phagocytes 
where p47phox expression is important for p67phox membrane translocation and absence of 
p47phox results in CGD (1).  To verify that the high level superoxide production induced by 
constitutively active Rac in COSphox cells was associated with membrane translocation of 
p47phox and p67phox, we examined protein localization in the COSphox cells by subcellular 
fractionation and by indirect immunofluorescence and confocal microscopy. 
Two independent experiments showed a 3- to 4-fold increase in the levels of p47phox 
and p67phox associated with the membrane fraction in COSphox cells transfected with Rac1V12 
compared to cells transfected with empty vector (Figs 4A & B).  This assay was performed on a 
bulk population of cells in which transient transfection efficiency was ~30%, as determined by 
immunohistochemistry to detect expression of the Myc-epitope tag on transgenic Rac.  
Densitometric analysis of cytosol and membrane fractions (Fig 4A and additional data not 
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shown) indicated that ~3% of cellular p47phox and p67phox were membrane-associated in the 
bulk COSphox cell population transfected with Rac1V12.  Thus, adjusting for transfection 
efficiency, the levels of p47phox and p67phox membrane association were ~10% in the 
COSphox cells which expressed Rac1V12.  These levels were comparable to the relative amount of 
p47phox and p67phox membrane association detected in activated neutrophils (9,51,52) or COSphox 
cells stimulated with the phorbol-ester PMA (45).  
As a second, independent method for determining p47phox and p67phox localization, we 
used indirect immunofluorescence and confocal microscopy.  In non-transfected or empty vector 
transfected COSphox cells, p47phox and p67phox were detected primarily in the cytosol; the 
cellular edges appeared soft and poorly defined because little p47phox or p67phox was 
associated with the plasma membrane (Fig 5A & B, respectively).  Transiently expressed 
constitutively active Rac1 derivatives (L61 or V12) concentrated along the plasma membrane 
and induced significant membrane ruffling (Fig 5D & F), as expected (53).  Increased plasma 
membrane association of p47phox and p67phox was apparent in COSphox cells expressing 
constitutively active Rac derivatives, as evidenced by a bright, clearly defined cellular border 
(Figs 5C & E), in marked contrast to the empty vector transfected cells (Fig 5A & B) or non-
transfected cells on the same slide (e.g. Fig 5E).  Cytosolic depletion of p47phox and p67phox 
immediately adjacent to the plasma membrane was typically also apparent in cells expressing 
constitutively active Rac (Fig 5C & E).
In intact neutrophils, agonist-elicited translocation of p47phox is dependent on 
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phosphorylation but does not require co-expression of p67phox (9).  To determine whether 
expression of constitutively active Rac could induce membrane translocation of p47phox in the 
absence of p67phox, a COS cell line which stably expressed only gp91phox, p22phox and 
p47phox was transiently transfected with constitutively active Rac derivatives and examined by 
confocal microscopy.  In contrast to empty vector-transfected cells, which resembled Fig 5A, 
membrane-associated p47phox was apparent in COS-91,22,47 cells expressing Rac1V12 (Fig 
5G).  This result indicates that expression of activated Rac was sufficient to induce membrane 
translocation of p47phox independent of p67phox expression, despite the fact that Rac does not 
directly bind p47phox (23,54).  Rac1L61 and Rac1V12/S30 also induced p47phox membrane 
translocation in COS-91,22,47 cells (data not shown).  p47phox membrane localization was less 
apparent but still detectable in COS-91,22,47 cells expressing Rac1V12/C40 (data not shown), 
consistent with the significantly decreased, but not absent, oxidase activity in Rac1V12/C40 
transfected COSphox cells (Figs 3A and C).     
p67phox does not translocate to the membrane in neutrophils derived from CGD patients 
who lack p47phox expression (9).  To determine whether overexpression of the constitutively 
active form of Rac could induce membrane translocation of p67phox in the absence of p47phox, 
the COS cell line which stably expressed only gp91phox, p22phox and p67phox was transiently 
transfected with activated Rac derivatives and examined by confocal microscopy.  p67phox 
membrane translocation was apparent in COS-91,22,67 cells expressing Rac1L61 (Fig 5H), 
indicating that high-level Rac-GTP expression could induce p67phox membrane translocation 
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in the absence of transgenic p47phox expression, possibly through direct p67phox interaction 
with overexpressed Rac-GTP.  Consistent with this, some low-level p67phox co-localization 
with transiently expressed Rac1L61 was also observed in COS cells which stably expressed only 
p67phox but not the flavocytochrome subunits (data not shown).  Rac1V12 and Rac1V12/C40 
derivatives also induced membrane translocation of p67phox, whereas little to no membrane 
localization of p67phox was observed in COS-91,22,67 cells expressing Rac1V12/S30, as 
expected (data not shown).
Activation of endogenous Rac1 by transgenic expression of Rac-GEFs is sufficient to 
activate the NADPH oxidase in COSphox cells.  To determine whether activation of endogenous 
Rac1 is sufficient to induce superoxide production in COSphox cells, we transiently expressed 
N-terminal truncated, constitutively activated forms of Rac guanine nucleotide exchange factors 
(GEFs), Vav1, Vav2, or Tiam1.  The expression levels of these three GEFs could not be directly 
compared to each other as they did not all have epitope tags.  Each stimulated significant 
superoxide production by the COSphox cells (Fig 6A).  Vav1 elicited superoxide production at a 
rate of 11 ± 1.5 nmol/107 cells/min (n=7), which was comparable to the Rac1L61-induced 
Vmax of 13 ± 0.5, n=4, and significantly higher than the Rac1V12-elicited Vmax of 5.8 ± 0.8, 
n=10 (Fig 1A).  Vav1-induced superoxide production could be completely inhibited by co-
expression of a dominant negative Rac1(T17N) derivative (data not shown), suggesting that the 
activated GEFs stimulated superoxide production through activation of Rac.  Levels of p47phox, 
p67phox, and Rac1 membrane association were increased in cells transfected with Vav1∆N-186 
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compared to empty vector transfected control cells (Fig 4A and B), consistent with the assembly 
of an active NADPH oxidase complex at the membrane of COSphox cells transfected with 
constitutively active Rac-GEFs.  
Activated Rac pull down assays confirmed that N-terminal truncated exchange factors 
each activated endogenous Rac1 in the COSphox cells, with an observed rank order of 
effectiveness of Tiam1>Vav2>Vav1 (Fig 6B).  Interestingly, although higher levels of activated 
Rac1 were detected upon transfection of either Tiam1 or Vav2, the constitutively active form of 
the hematopoietic-specific GEF, Vav1, was the most effective at activating superoxide 
production (Fig 6A).  Activated Rac represented ~1% of total endogenous Rac1 in cells 
transfected with activated Tiam1, as determined by densitometric analysis of immunoblots (not 
shown).  Since transient transfection efficiency was ~30%, activated Rac probably represented 
closer to 3% of endogenous Rac1 in the transfected cells which expressed activated Tiam1.  In 
parallel determinations, activated Rac represented ~1% of endogenous Rac1 in cells which 
expressed activated Vav2, and ~0.2% of endogenous Rac1 in cells which expressed activated 
Vav1.  Less than 0.01% of endogenous Rac was activated in cells transfected with empty vector.  
The level of Rac-GTP detected in GEF-transfected cells was at least two orders of magnitude 
less than that detected in Rac1L61 or Rac1V12 transfected cells (not shown), suggesting that a 
modest increase in the overall level of activated Rac was sufficient to activate the NADPH 
oxidase in COSphox cells.
Discussion
At least two separate events are required for assembly of the phagocyte NADPH oxidase 
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in intact cells: 1) phosphorylation of p47phox followed by membrane translocation of p47phox 
and p67phox, and 2) activation and membrane translocation of Rac.  How Rac activation 
contributes to regulation of the NADPH oxidase has not been fully elucidated.  It is well 
established that Rac-GTP is a component of the active oxidase complex, binding to both 
p67phox and also likely the flavocytochrome (1,23-29,55).  In this study, we show that in COSphox 
cells, activation of Rac, either by expression of V12 or L61 Rac derivatives or by expression of 
constitutively active Rac exchange factors, can itself drive membrane translocation of p47phox 
and p67phox and assemble a functional NADPH oxidase in the absence of any other stimulus.  
This contrasts with assembly of the NADPH oxidase in standard cell-free assay conditions, 
where activated Rac (added as Rac-GTPγS) is insufficient for initiating superoxide production 
unless an active conformation of p47phox is induced by the addition of an anionic amphiphile 
(1,13,14,16).  Optimal Rac-GTP–induced superoxide production required p47phox expression, 
as is the case for agonist-elicited oxidase activity in phagocytes and in another heterologous 
intact cell model based on the K562 chronic myelogenous leukemia cell line (56).  Tyrosine 
kinase inhibitors have been reported to partially inhibit agonist-elicited membrane translocation 
of Rac in intact human neutrophils, while having a minimal effect on p47phox and p67phox 
membrane translocation (55).  However, our results are not inconsistent with these observations, 
as residual Rac translocation may have been sufficient to activate p47phox and p67phox 
translocation in this study.  In addition, non-Rac dependent pathways for inducing NADPH 
oxidase assembly may also exist.  We therefore propose that Rac can play a dual role in NADPH 
oxidase activation in intact cells, both as a direct participant in the assembled oxidase and also as 
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an activator of signaling events leading to p47phox and p67phox membrane translocation.  
It is important to note that the COSphox cells are a model system that may lack proteins 
which could influence NAPDH oxidase assembly in response to activated Rac in phagocytes.  
For example, p40phox is not expressed in COS cells.  In resting neutrophils, p40phox is 
associated with p67phox and one third to one half of cellular p47phox in a high molecular weight 
cytosolic complex of undetermined stoichiometry, and translocates to the membrane upon 
cellular activation (57).  p40phox can also bind cytoskeletal proteins and phosphotidylinositol-
3’phosphate (58-61).  p40phox is not required for superoxide production in cell-free NADPH 
oxidase assays nor is it required for activation of the NADPH oxidase in heterologous K562 cells 
stimulated by either PMA or through a transgenic formyl peptide receptor (57,62)  In assays 
using either cell-free conditions or the K562 model, the addition of p40phox has been variously 
reported to exert either a positive or negative influence or have no effect at all on oxidase activity 
(58,63-68).  Hence, the role of p40phox in regulating NADPH oxidase activity and whether or 
not it might influence the response to Rac activation is unclear, but will be investigated in future 
studies.
In transgenic COS cells, expression of constitutively active Rac or constitutively active 
Rac-GEFs was sufficient to direct membrane translocation of p47phox and p67phox.  
Expression of constitutively active Rac1 derivatives also stimulated p47phox translocation to the 
plasma membrane, even in the absence of p67phox expression, although Rac-GTP does not 
directly bind to p47phox (23,54).  In neutrophils, current evidence indicates that p47phox 
Rac Activation Induces Phagocyte NADPH Oxidase Activity 
21
membrane translocation requires phosphorylation of multiple serine residues, including serines 
303, 304 and 328, in order to expose an SH-3 domain necessary for p47phox association with a 
proline-rich region on the p22phox flavocytochrome subunit (8-11,14).  The kinases which 
phosphorylate p47phox in vivo are unknown, although multiple protein kinases, including 
protein kinase C (PKC) and members of the PAK and MAPkinase families can phosphorylate 
p47phox in vitro  (69).  Rac is known to activate numerous downstream effector proteins, 
including phospholipase C-β2 (PLC-β2), as well as serine/threonine kinases, which regulate 
diverse signaling pathways (36,37), and we postulate that these can contribute directly or 
indirectly to p47phox membrane translocation.  Whether activated Rac and its downstream 
effector proteins induce p47phox phosphorylation in COSphox cells is currently under 
investigation.  In preliminary studies we have found that the protein kinase C (PKC) selective 
inhibitor GF109203x reduced Rac1V12-, Rac1L61-, and Vav1∆N-186-induced superoxide 
production by ~25% (data not shown).  Expression of constitutively active Rac1V12 or Rac1L61 
derivatives was also sufficient to induce p67phox membrane translocation in the absence of 
p47phox expression, probably through direct p67phox interaction with overexpressed Rac-GTP. 
Rac mutations that can selectively disrupt interaction with different effector proteins 
impaired Rac1V12-induced COSphox NAPDH oxidase activity, suggesting that multiple 
effectors mediate Rac-GTP induced oxidase activation.  Point substitutions (A27K) or (G30S), 
which prevent Rac interaction with p67phox (40,41), abrogated Rac1V12-elicited superoxide 
production in COSphox cells, confirming the importance of the interaction between Rac and 
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p67phox for NADPH oxidase activity.  The effector domain point substitution (Y40C), which 
abrogates Rac interaction with CRIB-domain dependent effector proteins (36,42) without 
affecting affinity for p67phox (43), reduced Rac1V12-induced NADPH oxidase activity by over 
2-fold, supporting the concept that Rac-GTP targets in addition to p67phox can mediate oxidase 
activation in intact cells.  Deletion of the insert domain (∆124-135) reduced Rac1V12-induced 
superoxide production by 40%, although with sufficient overexpression there was no inhibitory 
effect, suggesting that the insert domain primarily increases the affinity of Rac-GTP for the 
NADPH oxidase complex in intact cells, confirming observations from cell-free assays (44,70).  
Transient expression of N-terminally truncated, constitutively active Rac-GEF 
derivatives, Vav1, Vav2 or Tiam1, was sufficient to induce NADPH oxidase activity in 
COSphox cells.  Rac activation assays showed that expression of these GEFs activated at most 3% of 
endogenous Rac1, significantly less than the level of Rac1-GTP detected with transfection of 
V12 or L61 Rac1 derivatives.  This suggests that Rac activation in a physiologically relevant 
range is sufficient to activate the NADPH oxidase.  As a comparison, the chemoattractant fMet-
Leu-Phe (fMLP) activates between 2 and 10% of the total Rac in human neutrophils (50,71).   
Interestingly, the constitutively active form of the hematopoietic-specific GEF, Vav1, 
was the most effective at activating superoxide production, although higher levels of Rac1-GTP 
were detected upon transfection of either Vav2 or Tiam1 derivatives.  These results support the 
emerging concept that GEFs both regulate the activity of small GTPases and link their activation 
to specific functional responses (72).  That different GEFs are not functionally redundant but 
may help direct small GTPases toward specific downstream signaling pathways may account for 
the large number of identified GEFs – at least eight activate Rac in vitro  (72).  For example, 
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Bokoch and colleagues reported that Tiam1 potently activates Pak1 but not Jun N-terminal 
kinase (JNK) in COS-7 cells, even though both kinases are strongly activated by Rac-GTP (73). 
 Our results are also consistent with evidence suggesting differential regulation of downstream 
functions by the hematopoietic-specific Vav1 and widely expressed Vav2 isoforms, which are 
large multi-domain proteins and only 55% homologous (74).  In Jurkat T cells, antigen-induced 
activation of NFAT- or NFκB-dependent transcriptional pathways is strongly potentiated by 
overexpression of Vav1 but not Vav2 (75,76).  Furthermore, studies of Vav-deficient mice 
indicate that Vav1 and Vav2 differentially regulate various lymphocyte functions (74,77,78).  
The Vav GEFs are activated by tyrosine phosphorylation and by interaction between their 
pleckstrin homology (PH) domain and phosphatidyl inositol 3’ kinase (PI3K) lipid products (74). 
 Based on observations that fMLP-elicited Rac activation in human neutrophils is sensitive to 
tyrosine kinase and PI3K inhibition (50,55,71), Vav1 has been proposed to regulate phagocyte 
NADPH oxidase activation downstream of the Gi-coupled fMLP receptor.  Our data support a 
physiological role for Vav1 versus a subset of other Rac GEFs in promoting NADPH oxidase 
activation. 
In conclusion, our data suggest that Rac can play a dual role in NADPH oxidase 
activation, both as a direct participant in the oxidase complex and also as an activator of 
signaling events leading to oxidase assembly.  This model is supported by evidence that 
expression of constitutively active Rac derivatives was sufficient to induce NADPH oxidase 
activity in COSphox cells, in the absence of any other stimulus.  Expression of Rac1V12 drove 
membrane translocation of p47phox in the absence of p67phox expression, even though Rac-
GTP does not directly bind p47phox.  Furthermore, a Rac1V12/C40 derivative, which binds 
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p67phox but not CRIB-domain dependent effector proteins, was two-fold less effective than 
Rac1V12 at activating the NADPH oxidase in COSphox cells.  Taken together, this data supports 
a model in which Rac can promote NADPH oxidase assembly through activation of signaling 
pathways mediated by multiple effectors.  In the COSphox cells, activation of endogenous Rac1 
by transient expression of constitutively active Rac-GEF derivatives was also sufficient to 
induce robust NADPH oxidase activity.  Although higher levels of activated Rac1 were detected 
upon expression of Vav2 or Tiam1, Vav1 elicited the highest rate of superoxide production, 
suggesting that hematopoietic-specific Vav1 may more efficiently activate pathways leading to 
superoxide production.  These observations were made in a genetically tractable heterologous 
cell model, and further studies are underway to determine if similar mechanisms operate in 
neutrophils.
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Figure Legends
Figure 1 – Superoxide production in COSphox cells induced by expression of constitutively 
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active Rac derivatives.  (A) COSphox cells were transiently transfected with either empty pRK5 
vector, wt Rac1, Rac1V12, Rac1L61, or Cdc42L61.  0.2µg of each expression construct plus 1.8 
µg empty pRK5 vector was transfected per 60mm plate. Twenty-one hours post-transfection, 
cells were harvested for analysis and tested in the ferricytochrome c reduction assay without 
addition of any stimulus. Data represent mean ± SE, n = 3-10, *Rate of superoxide production 
was significantly greater than background observed with empty vector.  Also, the rate of 
superoxide production differed significantly between cells expressing Rac1L61 and Rac1V12; 
ANOVA followed by Student-Newman-Keuls multiple comparisons test, p<.001.  (B) Whole 
cell lysates (10µg) were separated by 12% SDS-PAGE, transferred to nitrocellulose and probed 
with monoclonal Ab to Rac1.  Transgenic Rac1L61 migrated more slowly than endogenous Rac1 
due to the Myc-epitope tag.  Rac1V12 migrated even more slowly due to both Myc- and 
polyglutamate-epitope tags.  Results are representative of at least three independent experiments.
Figure 2 – Effect of p47phox expression on Rac1L61-induced superoxide production in 
transgenic COS cell lines.  A COS cell line which stably expressed gp91phox, p22phox and 
p67phox was grown in 60mm dishes and transiently transfected with either (0.7 µg Rac1L61 + 1.4 µg 
empty pRK5), (0.7 µg each Rac1L61, p47phox and pRK5), or (0.7 µg each Rac1L61, p67phox 
and pRK5).  Twenty-one hours post-transfection cells were harvested and tested in the 
ferricytochrome c reduction assay without any stimulus. Data represent mean ± SE, n=3. *Rate 
of superoxide production differs significantly, two-tailed Student t-test, p< 0.05.
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Figure 3 – Superoxide production in COSphox cells expressing constitutively active Rac effector 
or insert domain mutants. (A) COSphox cells grown in 60mm plates were transiently transfected 
with 2µg empty pRK5 expression vector or with 1.97 µg empty pRK5 vector + 0.03µg of the 
indicated Rac derivatives.  Twenty-one hours post-transfection cells were harvested and tested 
in the ferricytochrome c reduction assay without addition of any stimulus. Data represent mean ± 
SE, n=5, *Rate of superoxide production differed significantly from that of Rac1V12-
transfected cells, ANOVA followed by Student-Newman-Keuls multiple comparisons test, p< 
0.05.  (B) Whole cell lysates (10µg) from cells transfected as in (A) were separated by 12% 
SDS-PAGE, transferred to nitrocellulose and probed with monoclonal Rac1 Ab.  Transgenic 
Rac migrated more slowly than endogenous Rac due to the epitope tag.  Results are 
representative of five independent experiments.  (C) COSphox cells in 60mm plates were 
transiently transfected with 2µg empty pRK5 expression vector or with the indicated Rac 
derivatives diluted 1:10 with empty pRK5 vector. Twenty-one hours post-transfection the cells 
were harvested and tested in the ferricytochrome c reduction assay without any stimulus.  Data 
represent mean ± SE, n=4. * Rate of superoxide production differed from that of Rac1V12 
transfected cells, ANOVA followed by Student-Newman-Keuls multiple comparisons test, p< 
0.05. (D) Whole cell lysates from cells transfected as in (C) were separated and transferred to 
nitrocellulose, as described above, then probed with monoclonal Rac1 Ab.  Transgenic Rac 
migrated more slowly than endogenous Rac1 due to the epitope tag.  Results are representative 
of four independent experiments.  
Figure 4. Subcellular fractionation and immunoblot analysis of p47phox and p67phox 
Rac Activation Induces Phagocyte NADPH Oxidase Activity 
33
localization in COSphox cells expressing constitutively active Rac1 or Vav1 derivatives.  (A) 
COSphox cells in 100mm plates were transfected with 4µg empty pRK5 vector, or 0.4µg 
Rac1V12 cDNA plus 3.6µg empty pRK5 vector, or 4µg Vav1∆N-186 cDNA.  Transient 
transfection efficiency averaged 30%.  Twenty-one hours post-transfection cells were harvested 
by brief trypsinization, disrupted in a Dounce homogenizer, and fractionated over a 
discontinuous 20%/38% sucrose gradient.  Membrane fractions (5 x 105 cell equivalents) and 
cytosol fractions (6 x 104 cell equivalents) were separated by SDS-PAGE, transferred to 
nitrocellulose, and probed with antibodies directed against NADPH oxidase subunits, p47phox, 
p67phox, Rac1 and p22phox.  Vav1∆N-186 expression was also confirmed by immunoblotting 
(not shown).  Blots are representative of two independent experiments. (B) The levels of 
p47phox and p67phox expression in membrane fractions were quantified by densitometric analysis of 
immunoblots.  Data were normalized against p22phox expression and represent the mean of two 
independent experiments.
Figure 5 – Immunofluorescence and confocal microscopy analysis of p47phox and p67phox 
localization in transgenic COS cell lines expressing constitutively active Rac1 derivatives.  COS 
cell lines were grown overnight on glass cover slips in 12-well plates, then transiently 
transfected with 0.9 µg empty pRK5 vector + 0.1µg cDNA (either Rac1V12 or Rac1L61).  
Twenty-one hours post-transfection cells were fixed with 4% paraformaldehyde, permeabilized 
with 0.05% Triton X-100, and blocked with 2% BSA/1% normal goat serum/PBS.  Cells were 
incubated with both mouse monoclonal Ab against Myc-epitope 9E10 (to detect transgenic Rac) 
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and with rabbit polyclonal Ab against either p47phox or p67phox.  Cells were then washed and 
incubated with both Cy 3-conjugated goat anti-mouse Ab and FITC-conjugated goat anti-
rabbit Ab.  Alternatively, cells were incubated with mouse monoclonal Ab against p47phox 
followed by FITC-conjugated goat anti-mouse Ab.  Focal planes spaced at 0.4µm intervals were 
imaged with a Zeiss 510 laser scanning confocal microscope (100X PlanApo 1.4 NA objective) 
equipped with LSM510 digital imaging software.  Three adjacent focal planes were averaged 
using Metamorph software.  Color images were converted to gray-scale using Adobe Photoshop 
6.0.  The bar in panel H represents 10µm; the field of view is the same size in all panels.  (A) 
p47phox localization in empty vector-transfected COSphox cells.  (B) p67phox localization in 
COSphox cells which do not express transgenic Rac.  (C & D)  p47phox and Rac1L61 localization, 
respectively, both in the same field of view of transfected COSphox cells.  (E and F) p67phox 
and Rac1L61 localization, respectively, both in the same field of view of transfected COSphox 
cells.  Arrows indicate the one cell which expressed Rac1L61 in this field of view.  (G) p47phox 
localization in two COS 91,22,47 cells expressing Rac1V12.  (H) p67phox localization in COS 
91,22,67 cells.  An asterisk marks the only cell which expressed Rac1L61 in this field of view. 
Figure 6 – Superoxide production and Rac activation in COSphox cells expressing constitutively 
active Rac-GEF derivatives.  COSphox cells were transiently transfected with constructs 
encoding Vav1∆N-186, Vav2∆N-191, Tiam1∆N-401, or with empty pRK5 expression vector 
(2µg DNA per 60mm plate).  (A) 21 hours post-transfection cells were harvested and tested in 
the ferricytochrome c reduction assay without any stimulus. Data represent mean ± SE, n = 4-7.  
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*p<.05, **p<.01, rate of superoxide production differs significantly, ANOVA followed by 
Student-Newman-Keuls multiple comparisons test.  (B) Cells were lysed in the presence of 
PAK1 PBD-GST and incubated with glutathione-Sepharose 4B beads.  Beads were pelleted and 
washed then resuspended in Laemmli buffer.  Aliquots of the supernatant containing Rac1-GDP 
(1 x 105 cell equivalents) and the pulldown containing Rac1-GTP (5 x 106 cell equivalents) 
were loaded on 12% gels and separated by SDS-PAGE, transferred to nitrocellulose, and probed 
with Rac1 monoclonal Ab.  Results are representative of two independent experiments.
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